Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria

Agonists targeting the kappa opioid receptor (KOR) have been promising therapeutic candidates because of their efficacy for treating intractable itch and relieving pain. Unlike typical opioid narcotics, KOR agonists do not produce euphoria or lead to respiratory suppression or overdose. However, the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Sci Signal
Autores principales: Brust, Tarsis F., Morgenweck, Jenny, Kim, Susy A., Rose, Jamie H., Locke, Jason L., Schmid, Cullen L., Zhou, Lei, Stahl, Edward L., Cameron, Michael D., Scarry, Sarah M., Aubé, Jeffrey, Jones, Sara R., Martin, Thomas J., Bohn, Laura M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5231411/
https://ncbi.nlm.nih.gov/pubmed/27899527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aai8441
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares